---
layout: page
title: FAQ
---

- What is the traditional drug design process?

- Where can AI help speed up the process?

- What is the current mix of drugs in the market in terms of small molecule / protein / other? 

- Is target identifaction the bottleneck step?

- How does target identifaction work? 

- How is drug design funded? 

- What is the interaction like between the following players: academia, big pharma, biotech startups, tech VC, biotech VC

- What does academia focus on?

- Who works on fundamental understanding of disease mechanisms?

